Skip to main content

Viridian Therapeutics, Inc.

VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001590750

In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Viridian Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
169
−2 vs. Q2 2025
Shares held
93.2M
−1.35M (−1.4%) vs. Q2 2025
Total value
$2.01B
+$689.4M (+52.1%) vs. Q2 2025
New holders
16
54 more added
Sold out
18
65 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 169 institutions
Q1 2021: 33 institutionsQ2 2021: 26 institutionsQ3 2021: 39 institutionsQ4 2021: 55 institutionsQ1 2022: 72 institutionsQ2 2022: 84 institutionsQ3 2022: 105 institutionsQ4 2022: 122 institutionsQ1 2023: 135 institutionsQ2 2023: 128 institutionsQ3 2023: 124 institutionsQ4 2023: 132 institutionsQ1 2024: 136 institutionsQ2 2024: 138 institutionsQ3 2024: 165 institutionsQ4 2024: 179 institutionsQ1 2025: 177 institutionsQ2 2025: 171 institutionsQ3 2025: 169 institutionsQ4 2025: 229 institutionsQ1 2026: 225 institutionsQ2 2026: 214 institutions
Value heldQ3 2025: $2.01B
Q1 2021: $84.5MQ2 2021: $109.8MQ3 2021: $223.7MQ4 2021: $459.8MQ1 2022: $460.9MQ2 2022: $327.7MQ3 2022: $778.5MQ4 2022: $1.21BQ1 2023: $1.10BQ2 2023: $1.12BQ3 2023: $769.9MQ4 2023: $1.31BQ1 2024: $1.24BQ2 2024: $906.2MQ3 2024: $1.98BQ4 2024: $1.75BQ1 2025: $1.23BQ2 2025: $1.32BQ3 2025: $2.01BQ4 2025: $3.36BQ1 2026: $2.21BQ2 2026: $2.50B
Institutions holding VRDN and their total value by quarter
QuarterHoldersValue
Q2 2026214$2.50B
Q1 2026225$2.21B
Q4 2025229$3.36B
Q3 2025169$2.01B
Q2 2025171$1.32B
Q1 2025177$1.23B
Q4 2024179$1.75B
Q3 2024165$1.98B
Q2 2024138$906.2M
Q1 2024136$1.24B
Q4 2023132$1.31B
Q3 2023124$769.9M
Q2 2023128$1.12B
Q1 2023135$1.10B
Q4 2022122$1.21B
Q3 2022105$778.5M
Q2 202284$327.7M
Q1 202272$460.9M
Q4 202155$459.8M
Q3 202139$223.7M
Q2 202126$109.8M
Q1 202133$84.5M

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q2 2025.

Institutions holding VRDN in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Rhumbline Advisers104,360$2.25M0.00%−3,025−2.8%Reduced
Wells Fargo & Company105,880$2.28M0.00%+26,099+32.7%Added
Swiss National Bank110,700$2.39M0.00%+1,800+1.7%Added
Knott David M Jr116,574$2.52M1.05%+25,091+27.4%Added
Russell Investments Group, Ltd.134,997$2.91M0.00%+47,112+53.6%Added
Millennium Management LLC136,280$2.94M0.00%+76,844+129.3%Added
UBS Asset Management Americas Inc138,980$3.00M0.00%−51,124−26.9%Reduced
Hennion & Walsh Asset Management, Inc.154,338$3.33M0.12%−13,986−8.3%Reduced
Macquarie Group Ltd154,739$3.34M0.00%−2,428−1.5%Reduced
Nuveen, LLC161,868$3.49M0.00%−61,367−27.5%Reduced
Hudson Bay Capital Management LP175,251$3.78M0.02%+55,689+46.6%Added
Morgan Stanley191,941$4.14M0.00%−8,426−4.2%Reduced
Kopp Family Office, LLC193,830$4.18M2.72%−9,400−4.6%Reduced
Bank of New York Mellon Corp197,170$4.25M0.00%+4,646+2.4%Added
Balyasny Asset Management LLC202,821$4.38M0.01%+202,821New
Barclays PLC208,246$4.49M0.00%−22,858−9.9%Reduced
Principal Financial Group Inc213,329$4.60M0.00%+9,493+4.7%Added
BNP Paribas Arbitrage, SA242,307$5.23M0.00%+52,078+27.4%Added
Ikarian Capital, LLC245,518$5.30M1.20%−224,431−47.8%Reduced
Bank of America Corp245,759$5.30M0.00%+14,915+6.5%Added
Affinity Asset Advisors, LLC250,000$5.39M0.50%−140,000−35.9%Reduced
Silverarc Capital Management, LLC259,509$5.60M0.81%+259,509New
JPMorgan Chase & Co309,133$6.67M0.00%−106,856−25.7%Reduced
Raymond James Financial Inc312,759$6.75M0.00%−19,330−5.8%Reduced
Driehaus Capital Management LLC344,084$7.43M0.05%−32,762−8.7%Reduced
Royal Bank of Canada368,601$7.96M0.00%+22,703+6.6%Added
Panagora Asset Management Inc377,711$8.15M0.03%+25,859+7.3%Added
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.423,272$9.13M0.71%00.0%Unchanged
Victory Capital Management Inc432,420$9.33M0.01%−132,370−23.4%Reduced
UBS Group AG447,677$9.66M0.00%−85,966−16.1%Reduced
HighVista Strategies LLC469,335$10.1M2.48%−15,224−3.1%Reduced
Yiheng Capital Management, L.P.500,261$10.8M3.57%00.0%Unchanged
Charles Schwab Investment Management Inc595,361$12.8M0.00%+21,340+3.7%Added
Rosalind Advisors, Inc.600,000$12.9M4.70%−100,000−14.3%Reduced
Northern Trust Corp620,862$13.4M0.00%+23,979+4.0%Added
Dimensional Fund Advisors LP638,777$13.8M0.00%+153,079+31.5%Added
5AM Venture Management, LLC736,595$15.9M5.82%00.0%Unchanged
Goldman Sachs Group Inc764,562$16.5M0.00%−135,263−15.0%Reduced
Woodline Partners LP815,485$17.6M0.08%00.0%Unchanged
Rice Hall James & Associates, LLC851,663$18.4M1.00%+336,040+65.2%Added
Candriam Luxembourg S.C.A.860,232$18.6M0.10%−2,041−0.2%Reduced
Marshall Wace, LLP869,188$18.8M0.02%−338,683−28.0%Reduced
Deutsche Bank AG937,467$20.2M0.01%+550,529+142.3%Added
Vivo Capital, LLC982,576$21.2M1.71%00.0%Unchanged
Pictet Asset Management Holding SA1,049,385$22.6M0.02%−216,369−17.1%Reduced
Wellington Management Group LLP1,122,532$24.2M0.00%+851,989+314.9%Added
Parkman Healthcare Partners LLC1,154,487$24.9M2.74%−144,338−11.1%Reduced
Fisher Asset Management, LLC1,201,226$25.9M0.01%+691,267+135.6%Added
Adage Capital Partners GP, L.L.C.1,220,128$26.3M0.04%+111,542+10.1%Added
Perceptive Advisors LLC1,462,400$31.6M0.91%+1,014,893+226.8%Added
Loomis Sayles & Co L P1,550,328$33.5M0.04%+211,856+15.8%Added
Baker Bros. Advisors LP1,744,406$37.6M0.27%00.0%Unchanged
Geode Capital Management, LLC1,766,187$38.1M0.00%+25,573+1.5%Added
Alliancebernstein L.P.1,859,458$40.1M0.01%−84,562−4.3%Reduced
Eversept Partners, LP1,924,306$41.5M3.18%+21,767+1.1%Added
Maverick Capital LtdSuperinvestorMaverick Capital2,212,701$47.8M0.64%−44,309−2.0%Reduced
Novo Holdings A/S2,380,000$51.4M3.31%00.0%Unchanged
Price T Rowe Associates Inc2,418,104$52.2M0.01%−477,161−16.5%Reduced
State Street Corp2,554,166$55.1M0.00%+7400.0%Added
Paradigm Biocapital Advisors LP2,609,353$56.3M1.67%−132,223−4.8%Reduced
Tang Capital Management LLC2,842,925$61.4M2.36%00.0%Unchanged
Commodore Capital LP3,200,000$69.1M3.37%−1,675,000−34.4%Reduced
Fairmount Funds Management LLC3,459,913$74.7M6.72%00.0%Unchanged
VR Adviser, LLC3,882,709$83.8M4.72%00.0%Unchanged
Vanguard Group Inc4,331,983$93.5M0.00%−176,525−3.9%Reduced
Kynam Capital Management, LP4,427,927$95.6M7.11%00.0%Unchanged
Deep Track Capital, LP5,380,449$116.1M3.24%00.0%Unchanged
BlackRock, Inc.5,428,521$117.1M0.00%−92,514−1.7%Reduced
FMR LLC12,249,355$264.3M0.01%+10,552+0.1%Added
UBS Oconnor LLC0$00.00%−131,294−100.0%Sold out
Diadema Partners LP0$00.00%−122,061−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−104,043−100.0%Sold out
Vestal Point Capital, LP0$00.00%−100,000−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−93,800−100.0%Sold out
Persistent Asset Partners Ltd0$00.00%−28,032−100.0%Sold out
Twinbeech Capital LP0$00.00%−22,417−100.0%Sold out
Algert Global LLC0$00.00%−18,693−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−17,401−100.0%Sold out
Engineers Gate Manager LP0$00.00%−16,504−100.0%Sold out
Virginia Retirement Systems Et Al0$00.00%−12,900−100.0%Sold out
Foresite Capital Management VI LLC0$00.00%−1,974−100.0%Sold out
Skopos Labs, Inc.0$00.00%−1,097−100.0%Sold out
Caitong International Asset Management Co., Ltd0$00.00%−173−100.0%Sold out
Point72 (DIFC) Ltd0$00.00%−54−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−44−100.0%Sold out
Riggs Asset Managment Co. Inc.0$00.00%−43−100.0%Sold out
Twin Peaks Wealth Advisors, LLC0$00.00%−26−100.0%Sold out